Pfizer Bivalent Covid Booster Gets FDA Nod for Infants, Toddlers

Pfizer Inc.’s bivalent shot for Covid-19 has received emergency approval to be used as a booster in some infants and toddlers.

Children between six months and four years old can receive the Pfizer-BioNTech SE shot at least two months after completing their primary series of vaccinations, the US Food and Drug Administration said Tuesday.

Kids who have already had a Pfizer-BioNTech bivalent vaccine aren’t approved to get jabbed again, because they’re adequately protected against the most serious Covid-19 complications, the FDA said

The authorization closes an inoculation gap for young children who were able to receive a series of ...